CD274 and neoplasm: The immune checkpoint proteins programmed death-1 (PD-1) and its ligand (PD-L1) form the PD-1/PDL-1 pathway, which protects tissues from immune-mediated damage and leads to the inhibition of cytotoxic T cells in the tumour micro-environment, inhibiting tumour destruction [48].